Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
Navigating the Bear Market: Dollar Cost Averaging vs. Lump Sum Investing
Navigating the stock market: comparing the pros and cons of dollar cost averaging and lump sum investing. Which is right strategy for you?
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx Limited (NYSE: VNRX) – Enters Commercial Stage for Nu.Q Vet Cancer Test
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
Boustead SG (SGX:F9D) – Share Price Undervalued, But Lack of Near Term Catalyst
SOTP valuation shows Boustead's share price is undervalued. However, there may be a lack of near term catalyst for a rerate of share price.
uniQure N.V. (NASDAQ:QURE) – World’s Most Expensive Medicine
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Service Corporation International (NYSE:SCI) – Profiting from “Death”
Service Corporation International (NYSE:SCI) is the leader in the death care industry and expected to grow as demand for its services increase. If an investor is looking for an investment in an industry that will always be in demand, SCI is an excellent choice.
Investing During a Market Crash
It's important to be aware of the dangers associated with investing during a market crash. Here are some key things to watch out for.
Quick thoughts on Adobe’s 20bn acquisition of Figma.
Adobe made news last night of acquiring a smaller company for $20 billion. The market reacted by dropping over $30 billion in market cap.
Credit Bureau Asia Ltd (SGX: TCU) – A Wide Moat Resilient Business
Credit Bureau Asia Ltd, a leading player in SEA credit and risk information solutions market, is a wide moat resilient business. Here's why.